The effect of glucocorticoids in the normal cerebral hemisphere of brain tumour patients

Acta Neurologica Scandinavica

Volumn 98, Issue 6, 1998, Pages 433-438

  Andersen, C ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Brain tumour; Glucocorticoid; MRI; Relaxation times; White matter

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRONTAL LOBE; HEMISPHERE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PROSPECTIVE STUDY; WATER CONTENT; WHITE MATTER;

EID: 0032443289     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb07326.x     Document Type: Article

References (29)

1. KOFMAN S, GARVIN JS, NAGAMANI D. Treatment of cerebral métastases from breast carcinoma with prednisolone. JAMA 1957;163:1473-6.
2. GALILICII JH, FRENCH LA. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract 1961;12:169-74.
3. BOUMPAS DT. Glucocorticoid therapy for immunemediated diseases: Basic and clinical correlates. Ann Int Med 1993;119:1198-208.
4. ANDERSEN C, HASELGROVE JC, DOENSTRUP S, ASTRUP J, GYLDENSTED C. Resorption of peritumoral edema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging. Acta Neurochir 1993;122:218-24.
5. ANDERSEN C, ASTRUP J, GYLDENSTED C. Quantitative MR analysis of glucocorticoid effects on peritumoral edema associated with intracranial meningiomas and métastases. J Comp Assist Tomogr 1994;18:509-18.
6. ANDERSEN C. In vivo estimation of cerebral white matter water content in brain tumor patients and normal individuals. Towards a quantitative brain oedema definition. Acta Neurochir 1997;139:249-56.
7. BELL BA, KEAN DM, MACDON'ALD HL et al. Brain water measured by magnetic resonance imaging. Lancet 19S7;329:66-9.
8. KAMMAN RL, Go KG, BERENDSEN HJC. Nuclear magnetic resonance in experimental brain edema: Effects of water concentration, protein concentration, and temperature. Magn Reson Med 1988;6:265-74.
9. HARVEY I, TOFTS PS, MORRIS JK, WICKS DAG, RON MA. Sources of T-l variance in normal human white matter. Magn Reson Imaging 1991;9:53-9.
10. TOFTS PS, Du BOULAY EPGH. Towards quantitative measurements of relaxation times and other parameters in the brain. Neuroradiology 1990;32:407-15.
11. FATOUROS PP, MARMAROU A, KRAFT K A, INAO S, SCHWARZ FP. In vivo brain water determination by T] measurements: effect of total water content, hydration fraction, and field strength. Magn Reson Med 1991;17:402-13.
12. IN DEN KLEEF JJE, CUPPEN JJM. RLSQ: TT2 and rho calculations, combining ratios and least squares. Magn Reson Med 1987;5:513-24.
13. ANDERSEN C, TAAGEHOJ JENSEN F. Precision, accuracy and image plane uniformity in NMR relaxation time imaging on a 1.5 T whole-body MR imaging system. Magn Reson Imaging 1994;12(4):775-84.
14. MAXWELL RE, LONG DM, FRENCH LA. The clinical effects of a synthetic glucocorticoid used for brain edema in the practice of neurosurgery. In: REULEN HJ, ed. Steroids and brain edema. Berlin: Springer Verlag, 1972:219-32.
15. HATAM A, YU ZY, BERGSTROM M, BERGGREN B, GREITZ T. Effect of dexamethasone treatment on peritumoral brain edema: Evaluation by computed tomography. J Comp Assist Tomogr 1982;6:586-92.
16. ANDERSEN C, TAAGEHOJ JENSEN F. Differences in bloodtumour-barrier leakage of human intracranial tumours. Quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir 1998:In press.
17. BROCK M, WIEGAND H, ZILLIG C, ZYWIETZ C, MOCK P, DIETZ H. The effect of dexamethasone on intracraniel pressure in patients with supratentorial tumors. In: PAPPIUS HM, FEINDEL W, eds. Dynamics of brain edema. Berlin: Springer Verlag, 1976:330-6.
18. SKJOETH J, BJERRE PK. Effect of glucocorticoids on ICP in patients with a cerebral tumour. Acta Neurol Scand 1997;96:167-70.
19. YAMADA K, USHIO Y, HAYAKAWA T, ARITA N, YAMADA N, MOGAMI H. Effects of methylprednisolone on peritumoral brain edema. J Neurosurg 1983;59:612-19.
20. LEENDERS KL, BEANEY RP, BROOKS DJ, LAMMERTSMA AA, HEATHER JD, McKENZiE CG. Dexamethasone treatment of brain tumor patients: Effects on regional blood flow, blood volume, and oxygen utilization. Neurology 1985;35:1610-16.
21. HOSSMANN K A. The pathophysiology of experimental brain edema. Neurosurg Rev 1989;12:263-80.
22. OHNTSHI T, SHER PB, POSNER JB, SHAPIRO WR. Capillary permeability factor secreted by malignant brain tumor. J Neurosurg 1990;72:245-51.
23. CONSTANTIN! S, TAMIR J, GOMORI MJ, SHOHAMI E. Tumor prostaglandin levels correlate with edema around supratentorial meningiomas. Neurosurgery 1993;33: 204-11.
24. GEPPERT M, OSTERTAO CB, SEITZ G, KIESSLINO M. Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol (Berl) 1990;80:629-34.
25. BARNES D, HARVEY I, MCüONALD WI, RON MA, MOORE S. The effect of chlorpromazine and methylprednisolone on NMR relaxation times in the normal cat brain. Magn Reson Med 1991;18:232-6.
26. HEDLEY-WHYTE ET, Hsu DW. Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol 1986;19:373-7.
27. OHATA K, MARMAROU A. Clearance of brain edema and macromolecules through the cortical extracellular space. J Neurosurg 1992;77:387-96.
28. FULIIAM MJ, BRUNETTI A, ALOJ L, RAMAN R, DWYER AJ, Di CIIIRO G. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg 1995;83:657-64.
29. MATIIUR-DE VRE R. Biomédical implications of the relaxation behaviour of water related to NMR imaging. Br J Radiol 1984;57:955-76.